Aseptuva is a promising Swiss-UK Medtech startup, with operations in Bern, Zurich, and Cambridge, committed to revolutionizing hospital infection prevention. Founded in 2021, the company's mission is encapsulated in its slogan: "Aseptuva is a Swiss-UK Medtech startup, with offices in Bern, Zurich & Cambridge, working to prevent hospital infections."
Focusing on the health care and medical devices industries, Aseptuva is pioneering the development of Class II (a,b) medical devices designed for the in-situ disinfection of catheters and tubes in intensive care unit environments. By preventing secondary infections such as VAP and CLABSI, their automated and targeted solutions could significantly lessen the strain on healthcare workers while enhancing patient care and reducing hospital stays and associated costs.
Most recently, on May 24, 2024, Aseptuva received a Non Equity Assistance investment from MassChallenge Switzerland, underscoring the startup's growing credibility and potential in the medical device space.